On September 28, 2017, VEGAS LEX Commercial group associate Anastasia Cheredova spoke at a key session on legislative innovations in drug provision, public procurement and compliance practices in the regions at the Fifth Partnership "Medicines of Russia - to Interdisciplinary Dialogue" in Kazan.

Ms. Cheredova talked about this year’s main trends in public procurement in the pharmaceutical industry, including the new judicial practice of delineating authority in determining the interchangeability of medicines. She specifically focused on the development of prior approaches to the interchangeability of medicines depending on the patient's needs, and on the requirements to procurement object description depending on the conditions of the drug’s use.

The forum participants – representatives of government agencies, pharmaceutical market leaders and state customers – also discussed the building of an information and analytical system for monitoring and control of drug procurement for state and municipal needs. They talked about reforming the pricing system; adopting the indicative pricing method for the VED list; re-registration of prices in 2017-2018; preliminary results of the pilot pharmaceutical labelling project and the possibility of extending the project to all drugs; the regulatory framework for the circulation of medical products for EAEU member states; the single drug market development trends and other issues.

***

* The Medicines of Russia Partnership is one of the most significant annual events aimed at resolving the problems of the Russian pharmaceutical industry. More than 300 industry specialists take part in the event. The speakers include representatives of the FAS Russia, the Ministry of Healthcare, the Ministry of Industry and Trade, Roszdravnadzor, suppliers of medicines and medical products, heads of the FAS regional departments, health authorities, state procurement committees, analytical and legal companies. The event is broadly covered by regional and federal media. Source:  website.

VEGAS LEX has extensive experience in advising drug and medical product manufacturers on various regulatory issues in the pharmaceutical and medical industries. More information about our services can be found .*

For more information on VEGAS LEX’s services to support public procurement, please go